Celiac disease. CME update for family physicians.

Por Devlin, Shane M., Andrews, Christopher N., Beck, Paul L.
Publicado em 2004

Complementary and alternative medications in the management of inflammatory bowel disease

Por Picardo, Sherman, Altuwaijri, Mansour, Devlin, Shane M., Seow, Cynthia H.
Publicado no Therap Adv Gastroenterol (2020)

A survey of perceptions and practices of complementary alternative medicine among Canadian gastroenterologists

Por Gallinger, Zane, Bressler, Brian, Devlin, Shane M, Plamondon, Sophie, Nguyen, Geoffrey C
Publicado em 2014

Anti-Aging Therapy with Human Growth Hormone Associated with Metastatic Colon Cancer in a Patient with Crohn’s Colitis

Por Melmed, Gil Y., Devlin, Shane M., Vlotides, George, Dhall, Deepti, Ross, Soraya, Yu, Run, Melmed, Shlomo
Publicado em 2008

Overview of subsequent entry biologics for the management of inflammatory bowel disease and Canadian Association of Gastroenterology position statement on subsequent entry biologic...

Por Devlin, Shane M, Bressler, Brian, Bernstein, Charles N, Fedorak, Richard N, Bitton, Alain, Singh, Harminder, Feagan, Brian G
Publicado em 2013

Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders

Por Andrews, Christopher N, Devlin, Shane M, Le Foll, Bernard, Fischer, Benedikt, Tse, Frances, Storr, Martin, Congly, Stephen E
Publicado no J Can Assoc Gastroenterol (2019)

Colometer: A real-time quality feedback system for screening colonoscopy

Por Filip, Dobromir, Gao, Xuexin, Angulo-Rodríguez, Leticia, Mintchev, Martin P, Devlin, Shane M, Rostom, Alaa, Rosen, Wayne, Andrews, Christopher N
Publicado em 2012

Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group

Por Sparrow, Miles P., Irving, Peter M., Baidoo, Leonard, Bressler, Brian, Cheifetz, Adam S., Devlin, Shane M., Harrell, Laura E., Jones, Jennifer, Kozuch, Patricia L., Melmed, Gil Y., Velayos, Fernando S., Siegel, Corey A.
Publicado em 2008

Defining quality indicators for best-practice management of inflammatory bowel disease in Canada

Por Nguyen, Geoffrey C, Devlin, Shane M, Afif, Waqqas, Bressler, Brian, Gruchy, Steven E, Kaplan, Gilaad G, Oliveira, Liliana, Plamondon, Sophie, Seow, Cynthia H, Williams, Chadwick, Wong, Karen, Yan, Brian M, Jones, Jennifer
Publicado em 2014

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

Por Papamichael, Konstantinos, Cheifetz, Adam S., Melmed, Gil Y., Irving, Peter M., Casteele, Niels Vande, Kozuch, Patricia L., Raffals, Laura E., Baidoo, Leonard, Bressler, Brian, Devlin, Shane M., Jones, Jennifer, Kaplan, Gilaad G., Sparrow, Miles P., Velayos, Fernando S., Ullman, Thomas, Siegel, Corey A.
Publicado no Clin Gastroenterol Hepatol (2019)

Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn’s Disease: A Canadian Multi-Centre Observational Cohort Study

Por Shim, Hang Hock, Ma, Christopher, Kotze, Paulo G, Seow, Cynthia H, Al-Farhan, Heba, Al-Darmaki, Ahmed K, Pang, Jack X Q, Fedorak, Richard N, Devlin, Shane M, Dieleman, Levinus A, Kaplan, Gilaad G, Novak, Kerri L, Kroeker, Karen I, Halloran, Brendan P, Panaccione, Remo
Publicado no J Can Assoc Gastroenterol (2018)